Find your next paid study

Pancreatic Ductal Adenocarcinoma

~$75 – $3,000

Actual pay is set by the research site.

TakedaNCT07613359

An Exosomal miRNA Based Predictive Model for Personalized Neoadjuvant Chemotherapy Selection in Pancreatic Ductal Adenocarcinoma

This study aims to develop and validate a predictive microRNA (miRNA) panel to assess the response to neoadjuvant chemotherapy (NACT) in patients with resectab…

City of Hope Medical CenterNCT07226154

Actual pay is set by the research site.

Development and Feasibility of a Behavioral Activation Intervention to Support Independence in Older Veterans at Risk for Functional Decline

As Veterans age, chronic health conditions increase their risk of functional limitations, or difficulty completing day-to-day activities independently. Older a…

Functional Independence

VA Office of Research and DevelopmentNCT05493241

~$10 – $675

Actual pay is set by the research site.

Urge IncontinenceUrgency-frequency SyndromeOveractive Bladder

Trial Time for Percutaneous Nerve Evaluation in Patients Undergoing Sacral Neuromodulation for Urgency Urinary Incontinence or Urgency-frequency: a Randomized Control Trial

Sacral neuromodulation (SNM) was approved by the Food and Drug Administration (FDA) for the treatment of urgency incontinence (UUI) in 1998. One of two trial p…

University of ChicagoNCT06226220

Actual pay is set by the research site.

Phase 1

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

This is a pilot study; patients will receive 131-I apamistamab prior to CAR T-cell infusion in order to determine the maximum tolerated dose of 131-I apamistam…

B-ALLDLBCLB ALL+8 more

Memorial Sloan Kettering Cancer CenterNCT04512716

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

Trial of Topical Fluorometholone as Adjunctive Therapy for Bacterial Corneal Ulcers

The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with …

Keratitis BacterialCorneal Ulcer (Diagnosis)

~$75 – $3,000

Actual pay is set by the research site.

Vishal JhanjiNCT07308938

Traumatic Brain InjuryMajor Depressive DisorderBipolar Disorder+4 more

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neu…

Massachusetts General HospitalNCT04296604

Actual pay is set by the research site.

Discerning the Abnormal Functional Connectivity Involving the Social Reciprocity Network in Autism Spectrum Disorder and the Impact of Transcranial Magnetic Stimulation in Mitigating the Abnormalities

There is no consensus regarding the neurological substrate underpinning ASD. The investigators describe the novel concept of "social reciprocity network" and h…

Autism Spectrum Disorder

Christiana Care Health ServicesNCT06807684

~$10 – $1,125

Actual pay is set by the research site.

Heart FailureCardiogenic ShockReduced Ejection Fraction Heart Failure

Initiation and Titration of Guideline Directed Medical Therapy in Heart Failure Cardiogenic Shock With Impella 5.5 for Cardiac Recovery: INTeGRATE

The study will evaluate the impact of a combined device-drug strategy with Impella 5.5 with best practices and optimized GDMT on heart recovery outcomes in pat…

~$10 – $1,050

Actual pay is set by the research site.

Abiomed Inc.NCT06965504

COPEBreast CancerFirst Line Therapy+1 more

Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial

To learn if the Creating Opportunities for Personal Empowerment (COPE) intervention is feasible, acceptable, and helpful (compared to usual care) in women with…

M.D. Anderson Cancer CenterNCT07610499

Actual pay is set by the research site.

Phase 1

Phase 1 Study of Anti-FLT3 Chimeric Antigen Receptor-redirected T Cells in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)

This is a phase 1 dose escalation study to determine the safety of anti-FLT3 CAR-T in subjects with R/R AML. The primary objective is to assess safety. Up to 1…

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Hemogenyx Pharmaceuticals LLCNCT06786533

~$150 – $4,200

Actual pay is set by the research site.

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recen…

Hematopoietic Cell TransplantSolid Organ TransplantRespiratory Viral Infection